1/2상모집 중단 (진행 중)

A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.

연구 개요

The main objectives of this study are to evaluate the safety and tolerability of bemarituzumab in combination with other anti-cancer therapies, and to evaluate the efficacy of bemarituzumab in combination with S-1 and oxaliplatin (SOX) and nivolumab as assessed by objective response.

스폰서: 리드: 암젠
적응증: Gastric Cancer, Gastroesophageal Junction Cancer
중재: Bemarituzumab, CAPOX, SOX, Nivolumab
목표 등록: 72명
시작일: 2022-05-17
완료(예정): 2026-08-12
등록번호: NCT05322577 · ClinicalTrials.gov ↗

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.